Article

Femtosecond laser may stabilize capsule edge

Femtosecond laser-assisted cataract surgery seems to provide precise control of IOL positioning after healing following surgery, according to William Culbertson, MD.

Chicago-Femtosecond laser-assisted cataract surgery seems to provide precise control of IOL positioning after healing following surgery, according to William Culbertson, MD.

“Some studies have indicated that better optical refractive results are achieved after laser cataract removal and capsulotomy, but the responsible factors were unknown,” said Dr. Culbertson, professor of ophthalmology, and director, Cornea and Refractive Surgery Services, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Dr. Culbertson and colleagues conducted a study in which they evaluated anterior capsular fibrosis and its effect during the first postoperative month to determine if it leads to IOL decentration or optic tilt. In this fellow eye study, they evaluated the changes in capsule size, shape, and fibrosis after laser capsulotomy and compared them between both eyes of 24 patients treated with manual capsulorhexis and the fellow eye treated with laser (Catalys, OptiMedica).

Investigators found that the manual group had more changes in diameter than the laser group (0.5-mm change versus 0.2-mm change, respectively). The circularity increased or decreased in both groups, but there was more splay in the manual group. Fibrosis developed in both groups equally and was not responsible for the changes, Dr. Culbertson said.

“The diameter, shape, and centration of the capsule in computer-controlled femtosecond laser anterior capsulotomies are accurate and reproducible,” he said.

He believes that the roundness of the capsule does not account for the difference in the changes in size over the month of the study and hypothesized that the effect of the laser somehow stabilizes the edge of the capsule.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.